- $4.66bn
- $6.81bn
- CA$3.19bn
- 51
- 90
- 56
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,877 | 1,488 | 2,829 | 3,512 | 3,190 |
Cost of Revenue | |||||
Gross Profit | 2,124 | 914 | 2,172 | 2,781 | 2,351 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,897 | 4,720 | -899 | 1,395 | 2,181 |
Operating Profit | -1,020 | -3,232 | 3,729 | 2,118 | 1,009 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1,192 | -3,148 | 3,164 | 1,562 | 1,053 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,033 | -2,520 | 2,364 | 1,147 | 799 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,033 | -2,520 | 2,364 | 1,483 | 570 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,033 | -2,520 | 2,364 | 1,483 | 570 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.098 | -0.792 | 0.738 | 1.49 | 1.65 |
Dividends per Share | |||||
Special Dividends per Share |